Assembly Biosciences, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Assembly Biosciences, Inc. (ASMB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$36.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-19
- Assembly Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$36.50M, a 496.74% decline from fiscal 2024.
- Assembly Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $9.20M, a 50.00% decline from fiscal 2023.
- Assembly Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $18.40M, a 31.60% decline from fiscal 2022.
- Assembly Biosciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $26.90M, a 4.26% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$36.50M 10-K · filed 2026-03-19 |
| 2024-12-31 | $9.20M 10-K · filed 2026-03-19 |
| 2023-12-31 | $18.40M 10-K · filed 2025-03-20 |
| 2022-12-31 | $26.90M 10-K · filed 2024-03-28 |
| 2021-12-31 | $25.80M 10-K · filed 2023-03-22 |
| 2020-12-31 | $22.80M 10-K · filed 2022-03-11 |
| 2018-12-31 | $28.40M 10-K · filed 2019-02-28 |
| 2017-12-31 | $28.40M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |